Skip Navigation


JAC Advance Access originally published online on January 29, 2008
Journal of Antimicrobial Chemotherapy 2008 61(3):533-540; doi:10.1093/jac/dkn008
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
61/3/533    most recent
dkn008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Yoon, E.-J.
Right arrow Articles by Choi, E.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoon, E.-J.
Right arrow Articles by Choi, E.-C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Original research

Foggy D-shaped zone of inhibition in Staphylococcus aureus owing to a dual character of both inducible and constitutive resistance to macrolide–lincosamide–streptogramin B

Eun-Jeong Yoon, Ae-Ran Kwon{dagger}, Yu-Hong Min and Eung-Chil Choi*

College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151-742, Korea

Received 14 November 2007; returned 27 December 2007; revised 15 December 2007; accepted 31 December 2007


* Corresponding author. Tel: +82-2-880-7874; Fax: +82-2-872-1795; E-mail: ecchoi{at}snu.ac.kr

Objectives: We identified Staphylococcus aureus strains having blunt inhibitory zones around the clindamycin or josamycin discs proximal to the erythromycin disc filled with slight bacterial growth. This ambiguous phenotype was termed as ‘macrolide–lincosamide–streptogramin B antimicrobial (MLSB) resistance having a foggy D-shaped inhibitory zone’ (fMLSB), and we tried to analyse its molecular mechanisms.

Methods: Forty-one clinically isolated strains of fMLSB S. aureus were studied. The regulatory region of the erm(A) gene, which was found to be the only molecular mechanism of fMLSB, was sequenced. Then, β-galactosidase assays were performed to observe their expression patterns through the nucleotide sequential alteration.

Results: According to the sequencing electropherogram, a grouping was made of a homogeneous nucleotide sequence group (73.2%) and a heterogeneous nucleotide sequence group (26.8%). The former group was composed of a 25 bp tandem duplication type and a 25 bp tandem triplication type. Their β-galactosidase activity was similar to that of constitutive MLSB resistance due to its high basal level. Nevertheless, the predicted mRNA secondary structure of the regulatory region maintains the stem–loops of inducible wild-type erm(A), and thereby its inducible character might be expected in vivo. Strains in the latter group were proven to have two different erm(A) genes, and then dual effect of expression was observed.

Conclusions: The ambiguous phenotype of fMLSB is due to its possessing the dual character of inducible and constitutive expression of erm(A). The dual character is due to having one erm(A) gene of dual character or coexistence of two characterized erm(A) genes simultaneously.

Keywords: fMLSB , MLSB , S. aureus , erm(A)


{dagger} Present address. Department of Herbal Skin Care, Daegu Haany University, Gyeongsan 712-715, Korea.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.